[Study on effect of PluronicF-127 and vascular endothelial growth factor composite delivery system for improving the survival of grafted fat].
To explore the effect of PluronicF-127 and Vascular endthelial growth factor(VEGF) delivery system on the survival of the grafted fat, we divided fat harvest under the same condition into 4 groups. One group served as blank control; the other 3 groups served for experiments with respective to DMEM containing 20 ng/ml VEGF; DMEM containing 30% Pluronic F-127; DMEM containing 20 ng/ml VEGF and 30% Pluronic F-127, and then we transplanted the 4 groups of fat, subcutaneously, on the back of 3 groups of BALB/c nude mice (8 mice per group; injecting 4 points per mouse; 0.2 ml per point). At 3 weeks, 6 weeks and 12 weeks, we dissected the fat grafts, measured their weight retention, and put them in histopathologic examination with the use of HE and CD34 staining. And we compared the weight retention and microvessel density (MVD) of each experiment group versus those of control group. The relation between adipose cell and PluronicF-127 was observed through electron microscope. The results reveal that the MVD and weight of pluronicF-127 and VEGF of the experiment groups are significantly greater than those of other groups. The PluronicF-127 and VEGF composite delivery system can significantly improve the blood circulation for fat transplantation, and increase the survival rate of grafted fat.
Xu
Jinghong
J
The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China. xujinghong2008@gmail.com
Liu
Youshan
Y
Tan
Weiqiang
W
Hong
Xiaoya
X
D000273:Adipose Tissue / Q000166:cytology / Q000637:transplantation*; D000818:Animals; D016503:Drug Delivery Systems; D005260:Female; D006085:Graft Survival / Q000187:drug effects*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D020442:Poloxamer / Q000008:administration & dosage*; D011897:Random Allocation; D042461:Vascular Endothelial Growth Factor A / Q000008:administration & dosage*
D042461:Vascular Endothelial Growth Factor A; D020442:Poloxamer